https://scholars.lib.ntu.edu.tw/handle/123456789/537503
標題: | Severe pulmonary complications after initial treatment with rituximab for the Asian-variant of intravascular lymphoma | 作者: | SHANG-JU WU WEN-CHIEN CHOU BOR-SHENG KO HWEI-FANG TIEN |
公開日期: | 2007 | 卷: | 92 | 期: | 1 | 起(迄)頁: | 141-142 | 來源出版物: | Haematologica | 摘要: | Rituximab improves response to treatment and outcome for patients with CD20+ B-cell tymphoma. Herein, however, we report the occurrence of severe pulmonary complications shortly after rituximab infusion in three patients with the newly diagnosed Asian variant of intravascular lymphoma. It is suggested that patients with this subtype of lymphoma are monitored carefully for possible drug reactions during the use of rituximab. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-33846916924&doi=10.3324%2fhaematol.10561&partnerID=40&md5=1d8f7166ba2ca5cd48d2ce7365742a64 https://scholars.lib.ntu.edu.tw/handle/123456789/537503 http://ntur.lib.ntu.edu.tw//handle/246246/225971 |
ISSN: | 0390-6078 | DOI: | 10.3324/haematol.10561 | SDG/關鍵字: | betamethasone; cyclophosphamide; diphenhydramine; mitoxantrone; paracetamol; prednisolone; rituximab; vincristine; article; B cell lymphoma; case report; disease severity; dyspnea; female; human; human tissue; hypotension; hypoxia; interstitial pneumonia; lung infiltrate; male; patient monitoring; respiratory distress; tachycardia; treatment outcome; treatment response; Aged; Antibodies, Monoclonal; Antigens, CD20; Antineoplastic Agents; Cytokines; Female; Humans; Inflammation; Lung Diseases; Lymphoma; Male; Middle Aged; Taiwan; Vascular Neoplasms |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。